Integral Diagnostics Dirección
Dirección controles de criterios 2/4
El CEO de Integral Diagnostics es Ian Kadish , nombrado en May 2017, tiene una permanencia de 7.5 años. compensación anual total es A$1.24M, compuesta por 66.3% salario y 33.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.25% de las acciones de la empresa, por valor de A$1.71M. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 1.8 años, respectivamente.
Información clave
Ian Kadish
Chief Executive Officer (CEO)
AU$1.2m
Compensación total
| Porcentaje del salario del CEO | 66.3% |
| Permanencia del CEO | 7.5yrs |
| Participación del CEO | 0.3% |
| Permanencia media de la dirección | 3yrs |
| Promedio de permanencia en la Junta Directiva | 1.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | AU$1m | AU$825k | -AU$61m |
| Mar 31 2024 | n/a | n/a | -AU$59m |
| Dec 31 2023 | n/a | n/a | -AU$58m |
| Sep 30 2023 | n/a | n/a | -AU$16m |
| Jun 30 2023 | AU$1m | AU$794k | AU$25m |
| Mar 31 2023 | n/a | n/a | AU$23m |
| Dec 31 2022 | n/a | n/a | AU$21m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | n/a | AU$781k | AU$15m |
| Mar 31 2022 | n/a | n/a | AU$18m |
| Dec 31 2021 | n/a | n/a | AU$22m |
| Sep 30 2021 | n/a | n/a | AU$26m |
| Jun 30 2021 | AU$2m | AU$736k | AU$31m |
| Mar 31 2021 | n/a | n/a | AU$32m |
| Dec 31 2020 | n/a | n/a | AU$32m |
| Sep 30 2020 | n/a | n/a | AU$28m |
| Jun 30 2020 | AU$1m | AU$635k | AU$23m |
| Mar 31 2020 | n/a | n/a | AU$22m |
| Dec 31 2019 | n/a | n/a | AU$21m |
| Sep 30 2019 | n/a | n/a | AU$21m |
| Jun 30 2019 | AU$876k | AU$549k | AU$21m |
| Mar 31 2019 | n/a | n/a | AU$19m |
| Dec 31 2018 | n/a | n/a | AU$17m |
| Sep 30 2018 | n/a | n/a | AU$16m |
| Jun 30 2018 | AU$711k | AU$489k | AU$15m |
Compensación vs. Mercado: La compensación total ($USD808.58K) de Ian está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD919.58K).
Compensación vs. Ingresos: La compensación de Ian ha aumentado mientras la empresa no es rentable.
CEO
Ian Kadish (61 yo)
7.5yrs
Permanencia
AU$1,243,752
Compensación
Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Director | 7.5yrs | AU$1.24m | 0.25% A$ 1.7m | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Chief Information Officer | 5.2yrs | sin datos | sin datos | |
| Company Secretary | less than a year | sin datos | sin datos |
3.0yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de IDX se considera experimentado (3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Director | no data | AU$1.24m | 0.25% A$ 1.7m | |
| Independent Non-Executive Director | 7.1yrs | AU$140.53k | 0.013% A$ 90.4k | |
| Independent Non-Executive Director | 2.3yrs | AU$137.50k | 0.036% A$ 248.2k | |
| Independent Non-Executive Director | 1.3yrs | AU$111.22k | 0.015% A$ 102.2k | |
| Independent Non-Executive Chairman | 1.2yrs | AU$168.37k | 0.066% A$ 448.3k |
1.8yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: La junta directiva de IDX no se considera experimentada (1.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.